v3.26.3
Net Loss Per Share Attributable to Common Shareholders (Tables)
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities not Include in Computation of Net Loss per Share

The Company did not include the securities in the following table in the computation of the net loss per share calculations for the three and nine months ended September 30, 2026 and 2025 because the effect would have been anti-dilutive during each period:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Outstanding options

 

 

6,647,199

 

 

 

6,730,917

 

 

 

6,647,199

 

 

 

6,730,917

 

Unvested restricted common shares

 

 

1,976,199

 

 

 

2,040,729

 

 

 

1,976,199

 

 

 

2,040,729

 

ESPP

 

 

5,179

 

 

 

5,829

 

 

 

5,179

 

 

 

5,829

 

Assumed conversion of the Notes

 

 

7,837,020

 

 

 

—

 

 

 

7,837,020

 

 

 

—

 

Total

 

 

16,465,597

 

 

 

8,777,475

 

 

 

16,465,597

 

 

 

8,777,475